ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?

Patients with coronavirus disease 2019 (COVID-19) have a wide variety of clinical outcomes ranging from asymptomatic to severe respiratory syndrome that can progress to life-threatening lung lesions. The identification of prognostic factors can help to improve the risk stratification of patients by...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Amico, Silvia, Tempora, Patrizia, Lucarini, Valeria, Melaiu, Ombretta, Gaspari, Stefania, Algeri, Mattia, Fruci, Doriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914632/
https://www.ncbi.nlm.nih.gov/pubmed/33567739
http://dx.doi.org/10.3390/ijms22041705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914632/
https://www.ncbi.nlm.nih.gov/pubmed/33567739
http://dx.doi.org/10.3390/ijms22041705

Ejemplares similares